Clinical Trial Update: Duloxetine for Menopausal Depression [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated duloxetine for menopausal depression with vasomotor symptoms, and results were posted after completion in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Menopause | Phase 4 | Status: COMPLETED | Results posted: 2014-08-21